Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 24159023)

1.

Infectious disease. Immune suppressant unexpectedly boosts flu vaccine.

Cohen J.

Science. 2013 Oct 25;342(6157):413. doi: 10.1126/science.342.6157.413. No abstract available.

PMID:
24159023
2.

Immunology. Flu antibodies stir new hope for treatment, vaccine.

Leslie M.

Science. 2009 Feb 27;323(5918):1160. doi: 10.1126/science.323.5918.1160. No abstract available.

PMID:
19251602
3.

Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.

Mayrhofer J, Coulibaly S, Hessel A, Holzer GW, Schwendinger M, Brühl P, Gerencer M, Crowe BA, Shuo S, Hong W, Tan YJ, Dietrich B, Sabarth N, Savidis-Dacho H, Kistner O, Barrett PN, Falkner FG.

J Virol. 2009 May;83(10):5192-203. doi: 10.1128/JVI.02081-08. Epub 2009 Mar 11.

4.

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.

Chen MW, Cheng TJ, Huang Y, Jan JT, Ma SH, Yu AL, Wong CH, Ho DD.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13538-43. doi: 10.1073/pnas.0806901105. Epub 2008 Sep 2.

5.

Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.

Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM.

Clin Vaccine Immunol. 2012 Feb;19(2):128-39. doi: 10.1128/CVI.05533-11. Epub 2011 Dec 21.

6.

A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.

Zheng L, Wang F, Yang Z, Chen J, Chang H, Chen Z.

BMC Infect Dis. 2009 Feb 12;9:17. doi: 10.1186/1471-2334-9-17.

7.

Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.

Nang NT, Song BM, Kang YM, Kim HM, Kim HS, Seo SH.

Influenza Other Respir Viruses. 2013 Mar;7(2):120-31. doi: 10.1111/j.1750-2659.2012.00363.x. Epub 2012 Apr 9.

PMID:
22487301
8.

Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.

Wu Q, Xiao S, Fan H, Li Y, Xu J, Li Z, Lu W, Su X, Zou W, Jin M, Chen H, Fang L.

Antiviral Res. 2011 Dec;92(3):493-6. doi: 10.1016/j.antiviral.2011.10.001. Epub 2011 Oct 12.

PMID:
22020305
9.

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM.

PLoS One. 2008 Jan 30;3(1):e1501. doi: 10.1371/journal.pone.0001501.

10.

Prospecting the influenza hemagglutinin to develop universal vaccines.

Donis RO, Cox NJ.

Clin Infect Dis. 2011 Apr 15;52(8):1010-2. doi: 10.1093/cid/cir129. No abstract available.

11.

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.

PLoS One. 2008;3(12):e3942. doi: 10.1371/journal.pone.0003942. Epub 2008 Dec 16.

12.

Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.

Ding H, Tsai C, Zhou F, Buchy P, Deubel V, Zhou P.

PLoS One. 2011 Mar 25;6(3):e17821. doi: 10.1371/journal.pone.0017821.

13.

[Construction and immunogenicity study of DNA vaccine expressing human H5N1 influenza virus hemagglutinin].

Huan LF, Yao LH, Chen AJ, Cheng CS, Jia RQ, Tian Q, Bo H, Guo JQ, Wang M, Shu YL, Zhang ZQ.

Bing Du Xue Bao. 2007 Sep;23(5):366-70. Chinese.

PMID:
17969853
15.

Hemagglutinin displayed baculovirus protects against highly pathogenic influenza.

Tang XC, Lu HR, Ross TM.

Vaccine. 2010 Oct 4;28(42):6821-31. doi: 10.1016/j.vaccine.2010.08.040. Epub 2010 Aug 18.

PMID:
20727393
16.

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.

Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Jan 29;27(5):773-85. doi: 10.1016/j.vaccine.2008.11.033. Epub 2008 Nov 28.

PMID:
19041677
17.

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.

Pandey A, Singh N, Vemula SV, Couëtil L, Katz JM, Donis R, Sambhara S, Mittal SK.

PLoS One. 2012;7(3):e33428. doi: 10.1371/journal.pone.0033428. Epub 2012 Mar 14.

18.

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).

Gambaryan AS, Lomakina NF, Boravleva EY, Kropotkina EA, Mashin VV, Krasilnikov IV, Klimov AI, Rudenko LG.

Influenza Other Respir Viruses. 2012 May;6(3):188-95. doi: 10.1111/j.1750-2659.2011.00291.x. Epub 2011 Sep 23.

PMID:
21951678
19.

Evaluation of the immune response to recombinant DNA vaccine and adenoviral vaccine co-expressing the M1 and HA genes of H5N1 influenza virus in mice.

Guo J, Yao L, Chen A, Liu X, Fu J, Xu P, Zhang Z.

Sheng Wu Gong Cheng Xue Bao. 2011 Jun;27(6):876-83.

PMID:
22034816
20.

Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.

Liu G, Song L, Reiserova L, Trivedi U, Li H, Liu X, Noah D, Hou F, Weaver B, Tussey L.

Vaccine. 2012 Nov 6;30(48):6833-8. doi: 10.1016/j.vaccine.2012.09.013. Epub 2012 Sep 18.

PMID:
23000130
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk